How should I treat laryngospasm that occurs during ketamine administration?

Management of Laryngospasm During Ketamine Administration

Immediately apply continuous positive airway pressure (CPAP) with 100% oxygen via reservoir bag and facemask while performing Larson's maneuver; if this fails and oxygen saturation is falling, administer propofol 1-2 mg/kg IV, followed by suxamethonium 1 mg/kg IV if laryngospasm persists with worsening hypoxia. 1, 2

Immediate Response Algorithm

Step 1: Recognition and Initial Intervention

• Call for help immediately upon recognizing laryngospasm, which may present as inspiratory "crowing" sounds, marked suprasternal recession ("tracheal tug"), or silent inspiration indicating complete obstruction 1, 2
• Apply CPAP with 100% oxygen using a reservoir bag and facemask while ensuring upper airway patency 1, 2
• Avoid any unnecessary airway stimulation that could worsen the spasm 1, 2

Step 2: Larson's Maneuver

• Place the middle finger of each hand in the "laryngospasm notch" (located between the posterior border of the mandible and the mastoid process) while simultaneously performing a jaw thrust 1, 2
• Apply deep pressure at this anatomical point, which may help terminate the spasm 1, 2

Step 3: Pharmacological Escalation

If laryngospasm persists or oxygen saturation is falling:

• Administer propofol 1-2 mg/kg IV as the first-line pharmacological intervention 1, 2
  • Low doses are effective for early laryngospasm 1
  • Larger doses are required for severe laryngospasm or total cord closure 1, 2

Step 4: Neuromuscular Blockade

If laryngospasm remains refractory with worsening hypoxia:

• Administer suxamethonium 1 mg/kg IV for total cord closure unresponsive to propofol 1, 2
• This provides rapid cord relaxation, permitting ventilation, re-oxygenation, and intubation if necessary 1, 2

Step 5: Alternative Routes (If IV Access Unavailable)

• Intramuscular route: 2-4 mg/kg suxamethonium 1, 2
• Intralingual route: 2-4 mg/kg suxamethonium 1, 2
• Intra-osseous route: 1 mg/kg suxamethonium 1, 2

Step 6: Adjunctive Management

• Prepare atropine to treat bradycardia that may accompany suxamethonium administration 1, 2
• In extremis, consider surgical airway (cricothyrotomy or tracheostomy) 1, 2

Critical Context: Ketamine and Laryngospasm Risk

Incidence and Risk Factors

• Laryngospasm occurs more frequently with intramuscular ketamine compared to intravenous administration 3
  • IM ketamine carries an odds ratio of 5.2 (95% CI 2.3-11.9) for laryngospasm compared to other routes 3
  • 69% of patients with laryngospasm in one study had received IM ketamine 3
• Propofol-ketamine combination regimens show increased laryngospasm risk (aOR 2.52) compared to propofol alone 4
• The FDA label notes that laryngospasm and airway obstruction are recognized respiratory adverse reactions to ketamine 5

Paradoxical Ketamine Effect

• While ketamine has been used as an adjunct to prevent laryngospasm in some contexts 1, case reports document ketamine-induced laryngospasm even during deep anesthesia and neuromuscular blockade 6
• This idiosyncratic effect may represent an underrecognized phenomenon 6

Prevention Strategies

Anesthetic Depth Management

• Maintain adequate depth of anesthesia throughout airway manipulation, as laryngospasm risk peaks during light planes of anesthesia 1, 2
• Avoid extubation during intermediate stages; extubate either while deeply anesthetized or fully awake 1, 2

Airway Preparation

• Perform suction under direct vision while the patient is deeply anesthetized to ensure the airway is clear of secretions, blood, or debris 1, 2
• Administer an antisialagogue prior to ketamine induction due to the potential for increased salivation 5
• Refrain from further airway stimulation until the patient is fully awake 1, 2

Pharmacological Prevention

• Topical lidocaine sprayed onto vocal cords at induction reduces laryngospasm risk after short procedures 1, 2
• Sevoflurane and propofol are the least irritating anesthetic agents and are associated with lower laryngospasm rates 1, 2
• For children with active upper respiratory infection, inhaled salbutamol (2.5 mg if <20 kg, 5 mg if ≥20 kg) given 30 minutes before anesthesia reduces perioperative cough and bronchospasm by approximately 50% with a trend toward fewer laryngospasms 2

Critical Pitfalls to Avoid

• Do not wait for spontaneous resolution—the vocal cords rarely reopen before severe hypoxia or death occurs 1, 2
• Do not use inadequate propofol doses—low doses suffice for early spasm, but larger doses are required for severe cases 1, 2
• Do not delay suxamethonium when hypoxia worsens with total cord closure 1, 2
• Avoid extubation during light anesthesia, which represents the highest-risk period 1, 2
• Ensure IV access before any anesthetic procedure in high-risk patients; alternative routes (IM, intralingual, intra-osseous) are only backups 2
• Rapid IV administration of ketamine may result in respiratory depression; administer slowly over 60 seconds 5

Post-Event Monitoring

Post-Obstructive Pulmonary Edema

• Monitor for post-obstructive pulmonary edema, which occurs in >50% of laryngospasm episodes involving forceful inspiratory effort against a closed airway 1, 2
• Clinical features include dyspnea, agitation, cough, pink frothy sputum, and falling oxygen saturations 1, 2
• Prompt recognition and treatment usually lead to resolution within hours 1, 2

Emergency Equipment Requirements

• Emergency airway equipment must be immediately available whenever ketamine is administered 5
• Continuously monitor vital signs in all patients receiving ketamine 5
• The FDA label emphasizes that ketamine should be administered by or under the direction of physicians experienced in general anesthetics, airway maintenance, and oxygenation/ventilation 5